2) Mitsuya H and Broder S: Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleoside. Proc Natl Acad Sci USA 83, 1911-1915 (1986)
3) Mitsuya H and Broder S: Long term inhibition of human T-lymphotropic virus type-3/lymphadenopathy-associtated virus (Human Immunodeficiency Virus, HIV DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in-vitro.) Proc Natl Acad Sci USA 84, 2033-2039 (1987)
4) Perry CM and Noble S: Didanosine / An update review of its use in HIV infection. Drug 58, 1099-1135 (1999)
5) Perry CM and Balfour JA: Didanosine / An update on its antiviral activity, pharmacokinetics properties and therapeutic efficacy in the management on HIV disease. Drug 52, 928-962 (1996)